Abstract
Aim To estimate the age-standardised prevalence of diabetes and prediabetes, and to identify factors associated with these conditions at individual, household, and community levels.
Methods Data from 11, 952 Bangladeshi adults aged 18+ available from the most recent nationally representative Bangladesh Demographic and Health Survey 2017-18 were used. Anthropometric measurements and fasting blood glucose samples were taken as part of the survey. Prevalence estimates of diabetes and prediabetes were age-standardised with direct standarisation, and risk factors were identified using multilevel mix-effects Poisson regression models with robust variance.
Results The overall age-standardised prevalence of diabetes was 12.8% (95%CI 11.2-14.3) (men: 12.8%, women: 12.7%), and prediabetes was 14.0% (95%CI 12.6-15.4) (men: 12.1%, women: 16.5%). Among people with diabetes, 61.5% were unaware that they had the condition. 35.2% were taking treatment regularly and only 30.4% of them had controlled diabetes. Factors associated with an increased prevalence of having diabetes were increasing age, male, overweight/obesity, hypertension, being in the highest wealth quintile and living in the Dhaka division. Compared with normal weight and currently unemployed, individuals who were underweight or currently employed were less likely to develop diabetes.
Conclusion Diabetes and prediabetes affect a substantial proportion (over one-quarter) of the Bangladeshi adult population. Continuing surveillance and effective prevention and control measures, with a particular focus on obesity reduction and hypertension management, are urgently needed.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
NA
Funding Statement
Study analysed secondary data and there was no funding for the study.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The survey, including biomarker measurements, was approved by the institutional review board of ICF and the National Research Ethics Committee of the Bangladesh Medical Research Council. Informed consent was obtained from all participants.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
This version has updated analysis based on Asian cut-off of BMI and also tightened discussion and policy implications.
Data Availability
Data will be available on request once the article is published
